Cargando…

A Short Corticosteroid Course Reduces Symptoms and Immunological Alterations Underlying Long-COVID

Despite the growing number of patients with persistent symptoms after acute SARS-CoV-2 infection, the pathophysiology underlying long-COVID is not yet well characterized, and there is no established therapy. We performed a deep immune profiling in nine patients with persistent symptoms (PSP), before...

Descripción completa

Detalles Bibliográficos
Autores principales:	Utrero-Rico, Alberto, Ruiz-Ruigómez, María, Laguna-Goya, Rocío, Arrieta-Ortubay, Estíbaliz, Chivite-Lacaba, Marta, González-Cuadrado, Cecilia, Lalueza, Antonio, Almendro-Vazquez, Patricia, Serrano, Antonio, Aguado, José María, Lumbreras, Carlos, Paz-Artal, Estela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614904/ https://www.ncbi.nlm.nih.gov/pubmed/34829769 http://dx.doi.org/10.3390/biomedicines9111540

Ejemplares similares

Alterations in Circulating Monocytes Predict COVID-19 Severity and Include Chromatin Modifications Still Detectable Six Months after Recovery
por: Utrero-Rico, Alberto, et al.
Publicado: (2021)

Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses
por: Almendro-Vázquez, Patricia, et al.
Publicado: (2022)

Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination
por: Almendro-Vázquez, Patricia, et al.
Publicado: (2021)

Hemodialysis-Associated Immune Dysregulation in SARS-CoV-2-Infected End-Stage Renal Disease Patients
por: González-Cuadrado, Cecilia, et al.
Publicado: (2023)

Defending against SARS-CoV-2: The T cell perspective
por: Almendro-Vázquez, Patricia, et al.
Publicado: (2023)

SARS-CoV-2-specific T-cell responses after COVID-19 recovery in patients with rheumatic diseases on immunosuppressive therapy
por: Lledó, Ana, et al.
Publicado: (2021)

Tolerogenic Role of Myeloid Suppressor Cells in Organ Transplantation
por: Ochando, Jordi, et al.
Publicado: (2019)

IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts
por: Utrero-Rico, Alberto, et al.
Publicado: (2021)

IL-6–based mortality risk model for hospitalized patients with COVID-19
por: Laguna-Goya, Rocio, et al.
Publicado: (2020)

Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome
por: Pleguezuelo, Daniel E., et al.
Publicado: (2021)

An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution
por: Gil-Etayo, Francisco Javier, et al.
Publicado: (2022)

Discordance Between SARS-CoV-2–specific Cell-mediated and Antibody Responses Elicited by mRNA-1273 Vaccine in Kidney and Liver Transplant Recipients
por: Fernández-Ruiz, Mario, et al.
Publicado: (2021)

Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency
por: Arroyo-Sánchez, Daniel, et al.
Publicado: (2021)

Derivation and external validation of a simple prediction rule for the development of respiratory failure in hospitalized patients with influenza
por: Ayuso, Blanca, et al.
Publicado: (2022)

Decreased breadth of the antibody response to the spike protein of SARS-CoV-2 after repeated vaccination
por: Horndler, Lydia, et al.
Publicado: (2023)

Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study
por: López-Medrano, Francisco, et al.
Publicado: (2021)

Perforin gene variant A91V in young patients with severe COVID-19
por: Cabrera-Marante, Oscar, et al.
Publicado: (2020)

Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19
por: San-Juan, Rafael, et al.
Publicado: (2022)

Cell-mediated and Neutralizing Antibody Responses to the SARS-CoV-2 Omicron BA.4/BA.5–adapted Bivalent Vaccine Booster in Kidney and Liver Transplant Recipients
por: Fernández-Ruiz, Mario, et al.
Publicado: (2023)

Shorter telomere length is associated with COVID-19 hospitalization and with persistence of radiographic lung abnormalities
por: Retuerto, Miriam, et al.
Publicado: (2022)

Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain
por: San-Juan, Rafael, et al.
Publicado: (2020)

Inborn Error of STAT2-Dependent IFN-I Immunity in a Patient Presented with Hemophagocytic Lymphohistiocytosis and Multisystem Inflammatory Syndrome in Children
por: López-Nevado, Marta, et al.
Publicado: (2023)

Impact of viral load at admission on the development of respiratory failure in hospitalized patients with SARS-CoV-2 infection
por: de la Calle, Cristina, et al.
Publicado: (2021)

Influence of viral load in the outcome of hospitalized patients with influenza virus infection
por: Lalueza, Antonio, et al.
Publicado: (2019)

A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem
por: Lalueza, Antonio, et al.
Publicado: (2021)

Characteristics of clinical trials of influenza and respiratory syncytial virus registered in ClinicalTrials.gov between 2014 and 2021
por: Lora, David, et al.
Publicado: (2023)

Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 Evolution
por: Garcinuño, Sara, et al.
Publicado: (2022)

Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study
por: de la Calle, Cristina, et al.
Publicado: (2021)

Effects of Inhaled Corticosteroids on the Innate Immunological Response to Pseudomonas aeruginosa Infection in Patients with COPD
por: Cerón-Pisa, Noemi, et al.
Publicado: (2022)

T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression
por: Gil-Etayo, Francisco Javier, et al.
Publicado: (2021)

Long-Term Follow-Up of Patients Diagnosed with COVID-19-Associated Pulmonary Aspergillosis (CAPA)
por: Ruiz-Ruigómez, María, et al.
Publicado: (2022)

COVID-19 in solid organ transplant recipients: A single-center case series from Spain
por: Fernández-Ruiz, Mario, et al.
Publicado: (2020)

Leukocyte redistribution as immunological biomarker of corticosteroid resistance in severe asthma
por: Cardoso‐Vigueros, Carlos, et al.
Publicado: (2022)

High Vancomycin MIC and Complicated Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Aguado, Jose Maria, et al.
Publicado: (2011)

Clinical Relevance of Corticosteroid Withdrawal on Graft Histological Lesions in Low-Immunological-Risk Kidney Transplant Patients
por: Hernández, Domingo, et al.
Publicado: (2021)

Immune Response Against SARS-CoV-2 Infection and Vaccination in a CD8α-Deficient Patient
por: Arroyo-Sánchez, Daniel, et al.
Publicado: (2023)

Isolated IgA Anti-β2 Glycoprotein I Antibodies in Patients with Clinical Criteria for Antiphospholipid Syndrome
por: Ruiz-García, Raquel, et al.
Publicado: (2014)

Renal Transplantation Dramatically Reduces IgA Anti-beta-2-glycoprotein I Antibodies in Patients with Endstage Renal Disease
por: Serrano, Manuel, et al.
Publicado: (2014)

Clinical Differences and Outcomes of COVID-19 Associated Pulmonary Thromboembolism in Comparison with Non-COVID-19 Pulmonary Thromboembolism
por: de Cossio, Santiago, et al.
Publicado: (2022)

Antibody-removal therapies for de novo DSA in pediatric intestinal recipients: Why, when, and how? A single-center experience
por: Lasa-Lázaro, María, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fd6vusped7rfl9o9pspa7vlt14